News Image

Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Portugal

Provided By GlobeNewswire

Last update: Jul 17, 2024

-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD)1 --

Read more at globenewswire.com

AMARIN CORP PLC -ADR

NASDAQ:AMRN (2/21/2025, 8:01:08 PM)

After market: 0.585 0 (-0.7%)

0.5891

0 (-0.82%)



Find more stocks in the Stock Screener

Follow ChartMill for more